The latest pharma company to make a move for an mRNA specialist is Germany's Merck KGaA ... as COVID-19 vaccines from Pfizer/BioNTech and Moderna – which both use lipid nanoparticles for ...
Merck & Co.’s first trial over the safety ... “RFK Jr.’s nomination and his views about vaccines were all over the news and we just thought it would make sense to push the trial back until ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback